Vaxiion Therapeutics (United States)

Chidamide (CS055/HBI-8000): a new histone deacetylase inhibitor of the benzamide class with antitumor activity and the ability to enhance immune cell-mediated tumor cell cytotoxicity

Zhiqiang Ning, Zhibin Li, Michael Newman et al. · Cancer Chemotherapy and Pharmacology · 2011 · 294 citations

Medicine, Oncology, Pharmacology +13

Preclinical evaluation of VAX-IP, a novel bacterial minicell-based biopharmaceutical for nonmuscle invasive bladder cancer

Shingo Tsuji, Xuguang Chen, Bryan Hancock et al. · Molecular Therapy — Oncolytics · 2016 · 22 citations · Full text

Medicine, Oncology, Pharmacology +12

Immunization with non-replicating E. coli minicells delivering both protein antigen and DNA protects mice from lethal challenge with lymphocytic choriomeningitis virus

Matthew J. Giacalone, Juan Carlos Zapata, Neil L. Berkley et al. · Vaccine · 2007 · 18 citations · Full text

Life Sciences, Immunology, Microbiology +12

A Single Intravesical Instillation of VAX014 Inhibits Orthotopic Superficial Bladder Tumor Implantation to Increase Survival

Bryan Hancock, Kathleen L. McGuire, Shingo Tsuji et al. · Anticancer Research · 2016 · 18 citations · Full text

Medicine, Oncology, Pharmacology +17

Intravesical VAX014 Synergizes with PD-L1 Blockade to Enhance Local and Systemic Control of Bladder Cancer

Shingo Tsuji, Katherine A. Reil, Kinsey L. Nelson et al. · Cancer Immunology Research · 2022 · 18 citations · Full text

Medicine, Oncology, Pharmacology +17